Stem Cell-Based Drug Discovery for Precision Medicine of Diabetes
Sunday, June 27 at 6:00 p.m.
Q＆A with Shuibing Chen, PhD
What is your presentation about?
Human pluripotent stem cells (hPSCs) provide a robust platform to evaluate type 1 and type 2 diabetes associated genes/SNPs. hPSC-derived cells/organoids can be applied to study the impact of genetic and environmental factors in diabetes progression. SARS-CoV-2 infection causes beta cell transdifferentiation.
What makes this topic important in 2021?
We studied the relationship between COVID-19 and diabetes.
Which subset of attendees shouldn’t miss this presentation?
We analyzed COVID-19 patient autopsy samples and SARS-CoV-2 infected human islets and found that SARS-CoV-2 infection causes beta cell transdifferentiation.
What else should Scientific Sessions attendees know about your presentation?
hPSC-derived cells/organoids are a powerful platform to systematically examine the impact of genetic and environmental factors in diabetes progression.
VIEW THIS PRESENTATION
Already registered?
View this presentation at ADA2021.org
Not yet registered?
Register now to access all presentations from the Virtual 81st Scientific Sessions